N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Volumn 27, Issue 1, 2016, Pages 55-61

  Habib, Mohammed ^a   Hillis, Alaa ^a   Hammad, Amen ^a  

^a European Gaza Hospital   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; CONTRAST MEDIUM; CREATININE; SCAVENGER;

ADVERSE EFFECTS; AGED; ANGIOCARDIOGRAPHY; BLOOD; CHEMICALLY INDUCED; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMBINATION; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; KIDNEY DISEASES; MALE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; AGED; ANTIOXIDANTS; ASCORBIC ACID; CARDIAC CATHETERIZATION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84964695007     PISSN: 13192442     EISSN: None     Source Type: Journal    
DOI: 10.4103/1319-2442.174072     Document Type: Article

References (0)